{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T14:44:56Z","timestamp":1775918696160,"version":"3.50.1"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":23,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Scientific Research Flanders","award":["FWO1S93026N"],"award-info":[{"award-number":["FWO1S93026N"]}]},{"DOI":"10.13039\/100001491","name":"Belgian American Educational Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001491","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Frans Van de Werf Fund"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Left ventricular outflow tract obstruction (LVOTO) drives symptoms and functional limitation in obstructive hypertrophic cardiomyopathy (oHCM). Some patients may only show treatment-qualifying obstruction during exercise echocardiography, yet their clinical profile and response to cardiac myosin inhibition are not well defined. This study compared the characteristics and therapeutic response of patients requiring exercise echocardiography to establish eligibility for mavacamten versus those meeting criteria at rest or during Valsalva.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>A single-centre retrospective cohort of 56 symptomatic oHCM patients treated with mavacamten was evaluated. LVOTO was assessed at rest, with Valsalva, and during exercise; patients were classified as \u2018exercise\u2019 or \u2018non-exercise\u2019 LVOTO based on the provocation manoeuvre eliciting a qualifying gradient (\u226550\u2005mmHg). Haemodynamic (Valsalva LVOT gradient) and symptomatic (NYHA class) response were assessed at 12 and 24 weeks. A total of 42.9% qualified for mavacamten exclusively during exercise echocardiography. Although resting and Valsalva gradients were lower by definition, these patients showed similar baseline functional limitation and exercise capacity (pVO2; 17.9 \u00b1 7.4 vs. 16.8 \u00b1 5.5\u2005mL\/kg\/min, P = .550). By 24 weeks, most patients in both groups achieved non-obstructive gradients (&amp;lt;30\u2005mmHg; 93.3% vs. 96.4%, P = .646) and NYHA class improvement (75.0% vs. 93.3%, P = .266), without significant between-group differences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Patients requiring exercise echocardiography to document treatment-qualifying LVOTO do not exhibit a milder disease phenotype and derive similar treatment benefits from mavacamten compared to those with resting or Valsalva-provoked obstruction. Exercise echocardiography identifies a substantial proportion of symptomatic HCM patients with significant LVOTO missed by resting assessment and is essential for guiding treatment eligibility.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/eschf\/xvag087","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T12:19:49Z","timestamp":1774268389000},"source":"Crossref","is-referenced-by-count":0,"title":["Role of provocation and exercise imaging for the identification of candidates for cardiac myosin inhibitors"],"prefix":"10.1093","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-3883-4102","authenticated-orcid":false,"given":"Jonas","family":"Erzeel","sequence":"first","affiliation":[{"name":"Department of Cardiology, Ziekenhuis Oost-Limburg , Genk ,","place":["Belgium"]},{"name":"Faculty of Medicine and Life Sciences\/LCRC, Hasselt University , Diepenbeek ,","place":["Belgium"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastiaan","family":"Dhont","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ziekenhuis Oost-Limburg , Genk ,","place":["Belgium"]},{"name":"Faculty of Medicine and Life Sciences\/LCRC, Hasselt University , Diepenbeek ,","place":["Belgium"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8233-9967","authenticated-orcid":false,"given":"Marnicq","family":"van Es","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ziekenhuis Oost-Limburg , Genk ,","place":["Belgium"]},{"name":"Faculty of Medicine and Life Sciences\/LCRC, Hasselt University , Diepenbeek ,","place":["Belgium"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duhan","family":"Ulgar","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ziekenhuis Oost-Limburg , Genk ,","place":["Belgium"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2412-8503","authenticated-orcid":false,"given":"Philippe","family":"Bertrand","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ziekenhuis Oost-Limburg , Genk ,","place":["Belgium"]},{"name":"Faculty of Medicine and Life Sciences\/LCRC, Hasselt University , Diepenbeek ,","place":["Belgium"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilfried","family":"Mullens","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ziekenhuis Oost-Limburg , Genk ,","place":["Belgium"]},{"name":"Faculty of Medicine and Life Sciences\/LCRC, Hasselt University , Diepenbeek ,","place":["Belgium"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pieter","family":"Martens","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ziekenhuis Oost-Limburg , Genk ,","place":["Belgium"]},{"name":"Faculty of Medicine and Life Sciences\/LCRC, Hasselt University , Diepenbeek ,","place":["Belgium"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,3,25]]},"reference":[{"key":"2026041109490139800_xvag087-B1","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Authors\/Task Force members","year":"2014","journal-title":"Eur Heart J"},{"key":"2026041109490139800_xvag087-B2","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1016\/j.jacc.2024.02.014","article-title":"2024 AHA\/ACC\/AMSSM\/HRS\/PACES\/SCMR guideline for the management of hypertrophic cardiomyopathy","volume":"83","author":"Ommen","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"2026041109490139800_xvag087-B3","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1161\/CIRCULATIONAHA.106.644682","article-title":"Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction","volume":"114","author":"Maron","year":"2006","journal-title":"Circulation"},{"key":"2026041109490139800_xvag087-B4","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1056\/NEJMoa021332","article-title":"Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy","volume":"348","author":"Maron","year":"2003","journal-title":"N Engl J Med"},{"key":"2026041109490139800_xvag087-B5","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1016\/j.jcmg.2017.07.016","article-title":"Role of exercise testing in hypertrophic cardiomyopathy","volume":"10","author":"Rowin","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026041109490139800_xvag087-B6","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.jchf.2017.09.011","article-title":"Clinical spectrum and management of heart failure in hypertrophic cardiomyopathy","volume":"6","author":"Maron","year":"2018","journal-title":"JACC Heart Fail"},{"key":"2026041109490139800_xvag087-B7","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.jacc.2021.12.002","article-title":"Diagnosis and evaluation of hypertrophic cardiomyopathy","volume":"79","author":"Maron","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2026041109490139800_xvag087-B8","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/s0140-6736(20)31792-x","article-title":"Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"396","author":"Olivotto","year":"2020","journal-title":"Lancet"},{"key":"2026041109490139800_xvag087-B9","doi-asserted-by":"publisher","first-page":"5071","DOI":"10.1093\/eurheartj\/ehae579","article-title":"Long-term effect of mavacamten in obstructive hypertrophic cardiomyopathy","volume":"45","author":"Garcia-Pavia","year":"2024","journal-title":"Eur Heart J"},{"key":"2026041109490139800_xvag087-B10","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1161\/CIRCULATIONAHA.124.072445","article-title":"Mavacamten in patients with hypertrophic cardiomyopathy referred for septal reduction: week 128 results from VALOR-HCM","volume":"151","author":"Desai","year":"2025","journal-title":"Circulation"},{"key":"2026041109490139800_xvag087-B11","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","article-title":"2023 ESC guidelines for the management of cardiomyopathies: developed by the task force on the management of cardiomyopathies of the European Society of Cardiology (ESC)","volume":"44","author":"Arbelo","year":"2023","journal-title":"Eur Heart J"},{"key":"2026041109490139800_xvag087-B12","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/s12265-021-10142-8","article-title":"Cardiopulmonary exercise testing with echocardiography to identify mechanisms of unexplained dyspnea","volume":"15","author":"Martens","year":"2022","journal-title":"J Cardiovasc Transl Res"},{"key":"2026041109490139800_xvag087-B13","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.jchf.2022.11.004","article-title":"Cardiopulmonary exercise testing with simultaneous echocardiography: blueprints of a dyspnea clinic for suspected HFpEF","volume":"11","author":"Verwerft","year":"2023","journal-title":"JACC Heart Fail"},{"key":"2026041109490139800_xvag087-B14","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.jacc.2024.05.029","article-title":"Exercise testing to unmask latent LVOT obstruction in a highly symptomatic patient with hypertrophic cardiomyopathy","volume":"84","author":"Husaini","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"2026041109490139800_xvag087-B15","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1136\/heartjnl-2013-304914","article-title":"Cardiac output response and peripheral oxygen extraction during exercise among symptomatic hypertrophic cardiomyopathy patients with and without left ventricular outflow tract obstruction","volume":"100","author":"Critoph","year":"2014","journal-title":"Heart"},{"key":"2026041109490139800_xvag087-B16","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.jtcvs.2022.05.025","article-title":"Cardiopulmonary exercise test in patients with obstructive hypertrophic cardiomyopathy","volume":"167","author":"Cui","year":"2024","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2026041109490139800_xvag087-B17","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.jchf.2023.10.004","article-title":"Exercise capacity in patients with obstructive hypertrophic cardiomyopathy","volume":"12","author":"Coats","year":"2024","journal-title":"JACC Heart Fail"},{"key":"2026041109490139800_xvag087-B18","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.3390\/jcm10112312","article-title":"Cardiopulmonary exercise test in patients with hypertrophic cardiomyopathy: a systematic review and meta-analysis","volume":"10","author":"Bayonas-Ruiz","year":"2021","journal-title":"J Clin Med"},{"key":"2026041109490139800_xvag087-B19","doi-asserted-by":"publisher","first-page":"e039551","DOI":"10.1161\/JAHA.124.039551","article-title":"Cardiopulmonary exercise testing for characterization of hypertrophic cardiomyopathy: a meta-analysis","volume":"14","author":"Landsteiner","year":"2025","journal-title":"J Am Heart Assoc"},{"key":"2026041109490139800_xvag087-B20","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ijcard.2010.08.026","article-title":"Chronotropic incompetence and its relation to exercise intolerance in hypertrophic cardiomyopathy","volume":"153","author":"Efthimiadis","year":"2011","journal-title":"Int J Cardiol"},{"key":"2026041109490139800_xvag087-B21","doi-asserted-by":"publisher","DOI":"10.1093\/eurjpc\/zwaf402","article-title":"Cardiopulmonary exercise testing in hypertrophic cardiomyopathy: the role of reduced O2 pulse and chronotropic incompetence in myocardial adaptation","author":"Willixhofer","year":"7, 2025","journal-title":"Eur J Prev Cardiol"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eschf\/advance-article-pdf\/doi\/10.1093\/eschf\/xvag087\/67522401\/xvag087.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/13\/2\/xvag087\/67522401\/xvag087.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/13\/2\/xvag087\/67522401\/xvag087.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T13:49:07Z","timestamp":1775915347000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/doi\/10.1093\/eschf\/xvag087\/8541406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,3]]},"references-count":21,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,3,25]]},"published-print":{"date-parts":[[2026,3,3]]}},"URL":"https:\/\/doi.org\/10.1093\/eschf\/xvag087","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4]]},"published":{"date-parts":[[2026,3,3]]},"article-number":"xvag087"}}